or Try an Advanced Search...

    Technical Analysis for PBM - Psyence Biomedical Ltd.

    Grade Last Price % Change Price Change
    F 0.07 0.29% 0.00
    PBM closed up 0.29 percent on Friday, November 1, 2024, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PBM trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.29%
    New 52 Week Low Weakness 0.29%
    BB Squeeze Ended Range Expansion 0.29%
    Wide Bands Range Expansion 0.29%
    Older End-of-Day Signals for PBM ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 1 day ago
    Down 2 % 1 day ago
    Possible NR7 1 day ago
    Down 1% 1 day ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PBM Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Psyence is a life science biotechnology company with a focus on natural psychedelics. The Psyence Biomed Division works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. Our name “Psyence” combines the words psychedelic and science to affirm our commitment to producing psychedelic medicines developed through evidence-based research.
    Classification
    Sector: Other
    Industry: Other
    Keywords: Biotechnology Entheogens Psychedelic Drug Psilocybin

    Is PBM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 2 Psyence Biomedical files to sell 10.9M common shares for holders
    Sep 20 Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
    Sep 19 Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs
    Sep 18 Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
    Sep 16 Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Sep 9 Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
    Sep 9 Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
    Sep 6 Psyence Biomedical to acquire drug developer Clairvoyant
    Sep 6 Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant
    Aug 30 Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
    See more PBM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.55
    52 Week Low 0.0673
    Average Volume 6,136,920
    200-Day Moving Average 0.78
    50-Day Moving Average 0.16
    20-Day Moving Average 0.10
    10-Day Moving Average 0.09
    Average True Range 0.02
    RSI (14) 28.06
    ADX 20.08
    +DI 18.60
    -DI 29.30
    Chandelier Exit (Long, 3 ATRs) 0.09
    Chandelier Exit (Short, 3 ATRs) 0.12
    Upper Bollinger Bands 0.12
    Lower Bollinger Band 0.07
    Percent B (%b) -0.09
    BandWidth 50.51
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.003
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.07
    Resistance 3 (R3) 0.07 0.07 0.07
    Resistance 2 (R2) 0.07 0.07 0.07 0.07
    Resistance 1 (R1) 0.07 0.07 0.07 0.07 0.07
    Pivot Point 0.07 0.07 0.07 0.07 0.07
    Support 1 (S1) 0.07 0.07 0.07 0.07 0.07
    Support 2 (S2) 0.07 0.07 0.07 0.07
    Support 3 (S3) 0.06 0.07 0.07
    Support 4 (S4) 0.06